Insiders · CNTX

CNTX insider transactions

Context Therapeutics Inc. (CNTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CNTX

• 65d
  SEC Form 4 filed by Chief Legal Officer, Corp. Sec Levit Alex C.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 65d
  SEC Form 4 filed by Chief Financial Officer Minai-Azary Jennifer Lynn

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 65d
  SEC Form 4 filed by Chief Medical Officer Chagin Karen Deborah

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 65d
  SEC Form 4 filed by Chief Executive Officer Lehr Martin A.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 321d
  SEC Form 4 filed by Director Pasternak Andy

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 321d
  SEC Form 4 filed by Director Kantoff Philip W.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 321d
  SEC Form 4 filed by Director Smith Karen L.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 321d
  SEC Form 4 filed by Director Stacey Jennifer Evans

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 321d
  SEC Form 4 filed by Director Walker Luke Nathaniel

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 321d
  SEC Form 4 filed by Director West Linda

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 323d
  Chief Executive Officer Lehr Martin A. bought $70,080 worth of shares (100,000 units at $0.70) (SEC Form 4)

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 323d
  Chief Legal Officer, Corp. Sec Levit Alex C. bought $11,520 worth of shares (20,000 units at $0.58), increasing direct ownership by 222% to 29,000 units (SEC Form 4)

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 323d
  Chief Financial Officer Minai-Azary Jennifer Lynn bought $25,486 worth of shares (40,010 units at $0.64), increasing direct ownership by 100% to 80,010 units (SEC Form 4)

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 324d
  SEC Form 4 filed by Chief Medical Officer Chagin Karen Deborah

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 324d
  SEC Form 3 filed by new insider Chagin Karen Deborah

  3 - Context Therapeutics Inc. (0001842952) (Issuer)
• 439d
  SEC Form 4 filed by Chief Financial Officer Minai-Azary Jennifer Lynn

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 439d
  SEC Form 4 filed by Chief Legal Officer, Corp. Sec Levit Alex C.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 439d
  SEC Form 4 filed by Chief Medical Officer Dansky Ullmann Claudio

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 439d
  SEC Form 4 filed by Chief Executive Officer Lehr Martin A.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 470d
  SEC Form 4 filed by Director Pasternak Andy

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 470d
  SEC Form 3 filed by new insider Pasternak Andy

  3 - Context Therapeutics Inc. (0001842952) (Issuer)
• 602d
  SEC Form 4 filed by Director Smith Karen L.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 602d
  SEC Form 3 filed by new insider Smith Karen L.

  3 - Context Therapeutics Inc. (0001842952) (Issuer)
• 602d
  SEC Form 4 filed by Director Walker Luke Nathaniel

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 602d
  SEC Form 3 filed by new insider Walker Luke Nathaniel

  3 - Context Therapeutics Inc. (0001842952) (Issuer)
• 636d
  SEC Form 4 filed by Chief Medical Officer Dansky Ullmann Claudio

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 636d
  SEC Form 3 filed by new insider Dansky Ullmann Claudio

  3 - Context Therapeutics Inc. (0001842952) (Issuer)
• 685d
  SEC Form 4 filed by Director Stacey Jennifer Evans

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 685d
  SEC Form 4 filed by Director Kantoff Philip W.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 685d
  SEC Form 4 filed by Director West Linda

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 685d
  SEC Form 4 filed by Director Berman Richard J

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 769d
  SEC Form 4 filed by Minai-Azary Jennifer Lynn

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 769d
  SEC Form 4 filed by Levit Alex C.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 769d
  SEC Form 4 filed by Lehr Martin A.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1064d
  SEC Form 4 filed by Kantoff Philip W.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1064d
  SEC Form 4 filed by West Linda

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1064d
  SEC Form 4 filed by Stacey Jennifer Evans

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1064d
  SEC Form 4 filed by Berman Richard J

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1163d
  SEC Form 4: Lehr Martin A. bought $4,900 worth of shares (5,823 units at $0.84), increasing direct ownership by 4% to 159,701 units

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1170d
  SEC Form 4 filed by Lehr Martin A.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1170d
  SEC Form 4 filed by Levit Alex C.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1170d
  SEC Form 4 filed by Minai-Azary Jennifer Lynn

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1171d
  SEC Form 4: Lehr Martin A. bought $4,901 worth of shares (5,606 units at $0.87), increasing direct ownership by 4% to 153,878 units

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1178d
  SEC Form 4: Lehr Martin A. bought $4,900 worth of shares (5,040 units at $0.97), increasing direct ownership by 4% to 148,272 units

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1185d
  SEC Form 4: Lehr Martin A. bought $4,901 worth of shares (7,027 units at $0.70), increasing direct ownership by 5% to 143,232 units

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1192d
  SEC Form 4: Lehr Martin A. bought $4,901 worth of shares (6,839 units at $0.72), increasing direct ownership by 5% to 136,205 units

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1197d
  SEC Form 4: Lehr Martin A. bought $4,995 worth of shares (6,783 units at $0.74), increasing direct ownership by 6% to 129,366 units

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1227d
  SEC Form 4: Minai-Azary Jennifer Lynn bought $18,500 worth of shares (25,000 units at $0.74), increasing direct ownership by 167% to 40,000 units

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1227d
  SEC Form 4: Lehr Martin A. bought $14,796 worth of shares (20,000 units at $0.74), increasing direct ownership by 19% to 122,583 units

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1234d
  SEC Form 4: Levit Alex C. bought $5,095 worth of shares (6,000 units at $0.85), increasing direct ownership by 200% to 9,000 units

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1346d
  SEC Form 4: Lehr Martin A. bought $24,064 worth of shares (13,000 units at $1.85), increasing direct ownership by 15% to 102,583 units

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1351d
  SEC Form 4: Minai-Azary Jennifer Lynn bought $27,000 worth of shares (15,000 units at $1.80)

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1351d
  SEC Form 4: Sahmoud Tarek bought $19,500 worth of shares (10,000 units at $1.95)

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1356d
  SEC Form 4 filed by Sahmoud Tarek

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1426d
  SEC Form 4 filed by West Linda

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1426d
  SEC Form 4 filed by Kantoff Philip W.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1426d
  SEC Form 4 filed by Berman Richard J

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1426d
  SEC Form 4 filed by Stacey Jennifer Evans

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1524d
  SEC Form 4 filed by Lehr Martin A.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)
• 1532d
  SEC Form 4 filed by Dick Evan G.

  4 - Context Therapeutics Inc. (0001842952) (Issuer)